MedTrace Logo

New Protocol for Febrile Neonate Management

NCT03183531 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 328

Last updated 2017-06-12

No results posted yet for this study

Summary

The objective of present study was to evaluate clinical and laboratory characteristics of febrile neonate and describe the incidence of SBI in febrile neonates. Secondarly investigators aimed to test usefulness of major protocols and new protocol in evaluating only febrile neonate.

Conditions

  • Newborn; Infection
  • Newborn Sepsis

Interventions

DIAGNOSTIC_TEST

C reactive protein

Addition of C-reactive protein test for management strategies to follow-up febrile neonates in outpatient.

Sponsors & Collaborators

  • Sisli Hamidiye Etfal Training and Research Hospital

    lead OTHER

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-01
Primary Completion
2015-12-31
Completion
2016-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03183531 on ClinicalTrials.gov